Investor Overview

Investor Overview

Xenon Pharmaceuticals 2020 AGM
June 1, 2020 at 11:30 am PDT

Company Profile

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.

Copyright West LLC. Minimum 15 minutes delayed.

Upcoming Events